5 completed, 2 unknown, 1 not yet recruiting. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Unknown 2, Not yet recruiting 1 |
Follow Muscle Hypotonia: new trials by email Literature Review of Muscle Hypotonia trials Research Report on Muscle Hypotonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Developing a Physiology-Pharmacodynamic Model of Rocuronium Dose and Cardiac Output to Investigate the Onset Time of Neuromuscular Relaxation Rocuronium dosing - Induction of Anaesthesia, Muscle Relaxants | Phase 4 | Not yet recruiting | Clare Hayes-Bradley | 32 | 2025-12-01 | 2025-11-25 |
| A Randomized Controlled Crossover Study Comparing Sugammadex and Placebo Sugammadex Injection [Bridion], Placebo - Posterior Cervical Decompression and Fusion | Phase 4 | Completed | University Health Network, Toronto | 40 | 2018-02-05 | 2020-06-17 |
| Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens Urine diagnostic testing as SOC, drug regimen changes per SOC, Urine diagnostic testing with selective PGx testing, drug regimen changes based on PGx test results - Target Drug-related Adverse Events | Phase 4 | Unknown | InSource Diagnostics | 14000 | 2015-12-01 | 2018-02-28 |
| The Effect of no Muscle Relaxant Versus Reduced-dose Rocuronium on Anesthesia in Adenotonsillectomy Rocuronium bromide 0.15 mg kg-1, Rocuronium bromide 0.3 mg kg-1, Fentanyl - Muscle Relaxants | Phase 4 | Unknown | Korea University Anam Hospital | 75 | 2015-07-01 | 2016-01-27 |
| Fade Upon TOF Stimulation Induced by Succinylcholine Succinylcholine - Muscle Relaxants | Phase 4 | Completed | University of Toledo Health Science Campus | 19 | 2015-04-01 | 2018-01-02 |
| Optimal Relaxation Technique for Laparotomies With Rocuronium Infusion Followed by Sugammadex Reversal Neostigmine, atropine, Sugammadex - Underdosing of Skeletal Muscle Relaxants for Laparotomy, Reversal of Skeletal Muscle Relaxant | Phase 4 | Completed | Hospital Sultanah Aminah Johor Bahru | 49 | 2012-02-01 | 2015-08-07 |
| Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients cisatracurium, Placebo, Cisatracurium besilate - ARDS | Phase 4 | Completed | Assistance Publique Hopitaux De Marseille | 340 | 2006-03-01 | 2008-10-10 |
| Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia Botulinum toxin, type B - Focal Dystonia | Phase 4 | Completed | Columbia University | 16 | 2003-04-01 | 2014-05-09 |
Dystonic Disorders (1) · Pneumonia (1) · Tremor (1)
Nervous System Diseases (8) · Neurologic Manifestations (8) · Neuromuscular Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Central Nervous System Diseases (1) · Dyskinesias (1) · Infections (1) · Lung Diseases (1) · Movement Disorders (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Sugammadex (2) · Atropine (1) · Fentanyl (1) · Neostigmine (1) · Propofol (1) · Rocuronium (1) · Saline Solution (1) · Sevoflurane (1) · Succinylcholine (1) · cisatracurium (1) · rimabotulinumtoxinB (1)
Assistance Publique Hopitaux De Marseille (1) · Clare Hayes-Bradley (1) · Columbia University (1) · Hospital Sultanah Aminah Johor Bahru (1) · InSource Diagnostics (1) · Korea University Anam Hospital (1) · University Health Network, Toronto (1) · University of Toledo Health Science Campus (1)
United States (3) · Canada (1) · France (1) · Malaysia (1)
Jang Eun Cho, M.D.,Ph.D. (1) · Lashmi Venkatraghavan (1) · Laurent Papazian, MD (1) · Seth Pullman, MD (1) · Shashi Bhatt, MD (1)